This is also the case with GFAP and NSE and although BNP is a cardiac peptide, it can also be elevated in diseases that cause secondary cardiac stress (e.g., pulmonary hypertension, stroke, renal insufficiency) (112–118). Here, ENO2 is linked to pulmonary arterial hypertension.